Search

everythinglearnresearchcommunity

for

Search:↓

Adding the topical gel improved hair growth more than using minoxidil or finasteride alone.

Squalene-based carriers improve delivery of a treatment to hair follicles for alopecia areata.

Surface-modified nanostructured lipid carriers can improve hair growth treatments.

Exosomes can help repair and heal tissues, improving health and vitality.

Human epidermal neural crest stem cells could be used for therapies, drug discovery, and disease modeling.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

Niosomes are the most effective at delivering drugs to the skin with minimal absorption into the body.

HAC and BAC improve skin targeting and reduce diffusion without causing irritation.

The model successfully predicted new uses for existing drugs, like using certain hormonal and heart medications for respiratory and Parkinson's diseases, and a cancer drug for diabetes.

New small molecule drugs could help treat hair loss.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

New nanocarriers improve skin drug delivery with low toxicity at certain concentrations.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

Hair testing is a reliable method for detecting workplace drug use when done with proper sample preparation and confirmation.

The paper concludes that drug labels should be clear for all, especially for those with low literacy, and suggests aiming for high comprehension test passing rates with diverse test populations.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Certain molecules in hair change with age and could be used for cosmetic treatments.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Understanding how EDC genes are regulated can help develop better drugs for skin diseases.

Finasteride use varies among Denmark, Finland, Norway, and Sweden, with higher usage in Finland and Sweden.

Nanofiber scaffolds help wounds heal by delivering drugs directly to the injury site.

Reviewers criticized the study for assuming drugs with similar side-effects work the same way and questioned the validity of its findings due to potential biases and data quality issues.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.